article thumbnail

The Road Ahead for Private Equity: Reflections and Predictions

JD Supra: Mergers

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

article thumbnail

Antitrust scrutiny of private equity deals intensifies

JD Supra: Mergers

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. By: Allen & Overy LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Private Equity: It Didn’t Start When We Think It Did

Deal Lawyers

That’s why this CLS Blue Sky Blog discussing a new article on the history of private equity caught my eye. If you’ve been reading this blog for a while, you know I’ve got a soft spot for M&A history. The blog says that although most M&A professionals would probably say that PE really began in […]

article thumbnail

California's AB 3129: Implications for Private Equity Investments in Physician Practices

JD Supra: Mergers

A recently introduced California Assembly Bill (AB 3129), targeting private equity (PE) physician practice investments, is currently making its way through the legislative process.

article thumbnail

2024 Healthcare Private Equity Outlook & Trends

JD Supra: Mergers

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.

article thumbnail

California’s AB 3129 Continues National Trend of Scrutinizing Private Equity Investments in the Health Care Industry

JD Supra: Mergers

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. By: Polsinelli

article thumbnail

Private Equity in Healthcare: Increased Scrutiny from FTC, DOJ, and HHS

JD Supra: Mergers

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown